When you have an important message to communicate—especially one that might be controversial or unpopular—you need more than just the message itself. You should equip yourself with a “messaging toolkit” that will help you effectively deliver (and justify) your message in various formats to various media.
A harsh reality of the digital age is that excellent content can languish in obscurity owing to its creators’ lack of knowledge about search engine optimization. And desktop search is far from the whole story. In fact, ignoring mobile search makes no sense.
It’s the tragedy of the Internet: Every cool thing that makes society more interconnected is in danger of being ruined by jerks. From misogynistic attacks on Twitter to racist comments on YouTube to general profane abuse in multiplayer video games, instances of online unpleasantness have raised questions about how to give everyone the best possible experience without crossing a line of censoring free speech.
For the Cincinnati Zoo, a horrible accident swiftly escalated into a full-blown crisis as animal rights activists and social media users were quick to criticize the zoo’s decision to take the life of the endangered animal to save a 4-year-old boy who fell into the zoo’s gorilla enclosure.
Social media works even better for B2B companies than B2C companies. Why? Because B2B companies traditionally have a smaller target audience and a higher average price point. Most importantly, however, a B2B’s customer decision funnel is even more influenced by word of mouth and reputation than a B2C company’s.
Considering the rash of certain brands’ ads, not many trust the adage, “Quality over quantity.”
Perhaps a few. Facebook posts by U.S. B2C brands actually fell 13% in Q1’ 16 vs Q1’ 15, according to Shareableedata provided exclusively to PR News. Still, consumer actions with those fewer posts remained flat year vs year. Actions are the sum of likes, shares and comments. Video pulled. B2Cs saw a 60% growth in Facebook video actions on a 40% rise in video content.
The topic of issues management has been around for decades. It’s examined and debated regularly in the PR industry mainly because it can be a very broad, overarching concept.
When the pressure of crisis management and an often-thorny public policy process are added to the mix, a conundrum can develop, especially for communicators with little to no experience in one or all of these areas. Issues management around public policy must be woven into an organization’s culture early, not just when things are tanking.
It’s a PR 101 conundrum: Charges are made against an important brand; the brand’s stature and the nature of the charges result in press coverage; the brand delays its response and a story is born. The brand then reaches out to the complainants and listens to their charges. Within a few days the brand investigates and concludes the charges are untrue. Some of the complainants agree with the brand’s assessment, while others say the investigation was faulty and demand increased transparency from the brand. The story results in many people thinking deeper about the brand and what it does. For some, the perception of the brand will change, if even just slightly.
This is a grossly simple way of looking at the story about conservative groups saying Facebook’s algorithm has been giving short shrift to stories with a conservative viewpoint. With 1 billion+ people using it each day, including 8 billion+ video views, Facebook arguably is the dominant social platform and a major component of brands’ social outreach.
The best sports organizations in the world are continually obsessed with recruiting the right team members. Building a team that will have the right chemistry to win and then retaining those administrators, players and coaches after they have achieved some level of success are perhaps the twin holy grails of sport.
The media shouldn’t feel too badly medical-testing firm Theranos is ignoring it ( PRN, Dec 21, 2015). Even Walgreens, which has a deal to set up thousands of Theranos blood-testing sites in its drugstores, received a cold shoulder. The pharmacist never even got a proper look at Theranos’ main testing device, Edison, The Wall Street Journal reported May 26 in a page 1 story.